Inactive Instrument
Protide Pharmaceuticals, Inc. Stock
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 2010-02-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 886K | |
| +1.68% | +3.19% | +3.55% | +10.22% | 49.42B | |
| +1.75% | +1.97% | +400.93% | +609.15% | 40.34B | |
| +2.07% | +0.34% | +28.22% | -5.33% | 34.01B | |
| +0.72% | +1.98% | +18.71% | +57.66% | 33.56B | |
| -2.09% | -0.80% | +3.56% | +33.56% | 26.84B | |
| -0.24% | +0.79% | - | - | 17.22B | |
| +0.43% | -4.32% | +66.22% | +120.64% | 15.19B | |
| -23.25% | -21.17% | +50.56% | +54.34% | 13.96B | |
| +2.59% | -0.49% | +15.24% | +20.83% | 13.36B | |
| Average | +6.79% | +0.83% | +73.38% | +112.63% | 27.1B | |
| Weighted average by Cap. | -0.34% | +0.90% | +88.01% | +135.01% |
Employees
3
Choose MarketScreener 
